Atlas Trials

Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)

Clinical trial NCT05396898 · COMPLETED

Trial details

NCT number
NCT05396898
Sponsor
University Hospital Tuebingen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Posttransplant Diabetes Mellitus
Start date
2020-12-16
Primary completion
2023-08-04
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.